Premium
Utility of the Acid‐Labile Metabolite (ALM) of Mephenytoin (MP) as a Probe for the CYP2C19 Metabolic Polymorphism
Author(s) -
Balian J.D.,
Flockhart D.A.,
Harns J.W.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.41
Subject(s) - mephenytoin , cyp2c19 , metabolite , pharmacology , chemistry , active metabolite , pharmacogenetics , medicine , metabolism , biochemistry , genotype , cytochrome p450 , gene
Clinical Pharmacology & Therapeutics (1996) 59 , 135–135; doi: 10.1038/sj.clpt.1996.41